TriCor
Links shared publicly online about this topic
TriCor for High cholesterol - Reviews Page 1 - Drugs - EverydayHealth.com
everydayhealth.com — “TriCor for High cholesterol Page 1, user reviews and ratings. I use this drug with other prescriptions for HPB and an elevated triglyeride level. i did notice that with tomatoes or oranges or anything with acidity-tend to create a rash simular to sunburned skin-i will be getting my blood labs done in march to see how it affected my cholestrol-no major complications.” View full resource at everydayhealth.com
Most Recently Shared on April 20, 2010 at 2:45 pm By:
RT @trinitymallmedi: TriCor Reviews Page 1 - Drugs A-Z - EverydayHealth.com http://bit.ly/cgmGxE
Generic TriCor, TriLipix, Abbott and Teva - Health Blog - WSJ
blogs.wsj.com — “Abbott has been jockeying for years to prevent generic competition for its cholesterol drug TriCor.” View full resource at blogs.wsj.com
Most Recently Shared on December 1, 2009 at 1:41 pm By:
How a Decades-Old Drug Is Still a Patented Blockbuster: Abbott isn’t likely to face generic competition on its ch... http://bit.ly/4GMDqm
Abbott, Teva Reach Deal That Delays Generic TriCor - WSJ.com
online.wsj.com — “Abbott Laboratories said it reached a deal with Teva Pharmaceuticals that postpones the sale of a generic version of its blockbuster cholesterol drug TriCor until March 28, 2011, at the earliest.” View full resource at online.wsj.com
Most Recently Shared on November 30, 2009 at 11:21 pm By:
Abbott, Teva Reach Deal That Delays Sales of Generic TriCor http://bit.ly/7cF1DP
Abbott’s TriCor With Statin Fails to Cut Diabetic Heart Risk - BusinessWeek
businessweek.com — “Adding Abbott Laboratories' cholesterol drug TriCor to an older, cheaper cholesterol pill failed to cut the risk of heart attacks, strokes and cardiac deaths in diabetics, a study found.” View full resource at businessweek.com
Most Recently Shared on March 14, 2010 at 4:10 pm By:
Bloomberg: Abbott’s TriCor With Statin Fails to Cut Diabetic Heart Risk. http://bit.ly/dtsc6Y
Abbott’s TriCor Fails To Beat A Sugar Pill « The Science Business - Forbes.com
blogs.forbes.com — “The results, significantly worse than Wall Street expected, are raising concern among some experts.” View full resource at blogs.forbes.com
Most Recently Shared on March 14, 2010 at 3:00 pm By:
low sodium foods Health Business
Abbott's TriCor Fails To Beat A Sugar Pill - Forbes (blog) http://bit.ly/bGGlkn
Fenofibrate Use Soars Despite Lack of Benefit (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- Prescriptions for fenofibrate (TriCor) and fenofibric acid (Trilipix) tripled from 2002 to 2009 -- even as clinical studies failed to confirm that they reduce cardiovascular events in diabetic patients, researchers said.” View full resource at qualitypointtech.net
Most Recently Shared on March 22, 2011 at 9:00 pm By:
Fenofibrate Use Soars Despite Lack of Benefit (CME/CE): (MedPage Today) -- Prescriptions for fenofibrate (TriCor) ... http://bit.ly/iaruxW
Subscription Center - News Archive
pharmalive.com — “Subscription Center - News Archive” View full resource at pharmalive.com
Most Recently Shared on December 1, 2009 at 8:49 pm By:
PharmaLive Pharma and Health News
Abbott Gives Teva TriCor Rights as Early as 2011 - http://tinyurl.com/ye653p6
UPDATE 1-No heart benefit seen with fibrates in diabetics | Reuters
reuters.com — “* Fibrates fail to cut heart risk when added to statins * Study tests Abbott's TriCor plus statins in diabetics * TriCor cuts risk in those with higher triglycerides (Adds study details, researcher” View full resource at reuters.com
Most Recently Shared on March 14, 2010 at 12:55 pm By:
low sodium foods Health Business
No heart benefit seen with fibrates in diabetics - Reuters http://bit.ly/cHzprM
Use of fibrates to lower cholesterol growing despite mounting evidence they don't work - latimes.com
latimes.com — “The use of fibrates and fenofibrates to reduce cholesterol levels has grown sharply in the United States over the past decade, despite mounting evidence that the drugs provide little benefit, researchers reported Tuesday. Moreover, physicians are increasingly prescribing brand-name versions of the drugs, such as TriCor and Trilipix, despite the fact that published evidence so far shows a benefit only for generic forms of the drugs, such as gemfibrozil, researchers reported in the Journal of the ” View full resource at latimes.com
Most Recently Shared on March 23, 2011 at 1:03 am By:
LA Times Health News Health News
Use of fibrates to lower cholesterol growing despite mounting evidence they don't work http://lat.ms/fRpPk0
Abbott Labs' Deal with Teva Pharma Is 'Phat News' for Lipid-Lowering Franchise | BNET Pharma Blog | BNET
industry.bnet.com — “Abbott Laboratories has settled U.S. patent litigation with Teva Pharmaceutical over Abbott ’s blockbuster triglycerides drug TriCor. The licens” View full resource at industry.bnet.com
Most Recently Shared on December 14, 2009 at 5:25 pm By:
Jim Edwards Health Communicator
Abbott Labs' Deal with Teva Pharma Is 'Phat News' for Lipid-Lowering Franchise: Abbott Laboratories has settled U.S... http://bit.ly/6B4snR
TriLipix Study a Setback for Abbott - NYTimes.com
nytimes.com — “The study showed no significant reduction in heart attacks, strokes and cardiac deaths in people taking TriCor along with simvastatin, compared with those taking simvastatin alone.” View full resource at nytimes.com
Most Recently Shared on May 18, 2011 at 12:29 pm By:
A study has suggested thatTriLipix, does not protect against heart attacks or strokes better than a generic medicine http://nyti.ms/mLoXWX
TriLipix Study a Setback for Abbott - NYTimes.com
nytimes.com — “The study showed no significant reduction in heart attacks, strokes and cardiac deaths in people taking TriCor along with simvastatin, compared with those taking simvastatin alone.” View full resource at nytimes.com
Most Recently Shared on May 18, 2011 at 3:50 am By:
Studies show med does protect against heart attack or stroke...http://nyti.ms/jAoP6Q
Why Is Abbott’s TriLipix Defying Gravity? - Science Business - research, innovation & policy - Forbes
blogs.forbes.com — “Last week, Abbott Laboratories issued a sunny report about their blockbuster lipid drugs, TriLipix and TriCor, which are formulations of fibrates. In a sagging economy, the company issued the good news that sales of these drugs grew 28 percent from last year, to $372 million in the first quarter. This report [...]” View full resource at blogs.forbes.com
Most Recently Shared on April 29, 2011 at 5:21 pm By:
Harlan Krumholz Internist, Cardiologist, Physician, and Doctor
Why Is Abbott's TriLipix Defying Gravity? http://t.co/HBWN84X via @forbes
TriLipix Study a Setback for Abbott - NYTimes.com
nytimes.com — “The study showed no significant reduction in heart attacks, strokes and cardiac deaths in people taking TriCor along with simvastatin, compared with those taking simvastatin alone.” View full resource at nytimes.com
Most Recently Shared on May 18, 2011 at 6:43 am By:
Drug Study a Setback for Abbott http://bit.ly/k3blFU
TriLipix Study a Setback for Abbott - NYTimes.com
nytimes.com — “The study showed no significant reduction in heart attacks, strokes and cardiac deaths in people taking TriCor along with simvastatin, compared with those taking simvastatin alone.” View full resource at nytimes.com
Most Recently Shared on May 18, 2011 at 9:44 am By:
Kent Bottles, MD Doctor, Pathologist, and Physician
http://ow.ly/4X9To TriLipix + Simvastatin no better than Simvastatin alone for Cardiovascular diseases
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Everyday Health
Everyday Health inspires your health goals and supports your progress through expert guidance and breaking health news. Tweets managed by @anniehauser
-
Knoxville Hospital
Knoxville Hospital & Clinics is located in Knoxville, IA - We are the premier healthcare facility in south central Iowa
-
WSJ Health
Health news coverage from the Wall Street Journal
Advertisement
